Alcohol use disorder

There are 198 papers on alcohol use disorder in aging research: 10 trials and 126 observational studies in people, 7 in animals, 42 reviews. The newest story, Nov 7, 2026: “Sleep patterns linked to irregular heartbeat risk in Fitbit users”.

Disease

198 papers study it85 more mention it66 findings

22 new papers in 30 daysSee all 283 papers on alcohol use disorder

At a glance

Alcohol use disorder is linked with higher dementia risk and worse cognition in human cohorts. Studies also associate it with faster epigenetic aging and shorter telomeres, while others report no clear telomere-length link.

66 findings in 51 papers from 2018 to 2026, 11 of them since April 2026

“Higher genetically-predicted AUD (inverse variance-weighted (IVW) β = -0.06, 95% confidence interval (CI): -0.10 to -0.02, p = 0.001) was associated with shorter telomere length.”
Alcohol consumption and telomere length: Mendelian randomization clarifies alcohol's effectsMolecular psychiatry2022doi:10.1038/s41380-022-01690-9
  • Human trial10
  • Humans126
  • Animals7
  • In silico8

Interventions

3

Incretin receptor agonists

downin humans1

1 study
  1. Incretin receptor agonists decrease alcohol use disorder in humans.

    “Replicated evidence supports effects on alcohol and substance use disorders”

    Review

    Are Incretin Receptor Agonists Psychiatric Drugs: Near-term Opportunity or Creative Superlative?

    Psychiatry and clinical psychopharmacology

More on Incretin receptor agonists

Dulaglutide

no changein humans1

1 study
  1. Dulaglutide was not clearly linked with alcohol use disorder in humans (versus DPP4 inhibitor reference, propensity-score matched cohort).

    “Tirzepatide and semaglutide (but not liraglutide or dulaglutide) were associated with significant risk reduction of incident AUD compared to DPP4i”

    Humansversus DPP4 inhibitor reference, propensity-score matched cohort18 monthsn = 19,061

    Relative efficacy of GLP-1 and GLP-1/GIP receptor agonists in the prevention of alcohol-use disorders using a target trial emulation approach

    Diabetes, obesity & metabolism

More on Dulaglutide

Liraglutide

no changein humans1

1 study
  1. Liraglutide was not clearly linked with alcohol use disorder in humans (versus DPP4 inhibitor reference, propensity-score matched cohort).

    “Tirzepatide and semaglutide (but not liraglutide or dulaglutide) were associated with significant risk reduction of incident AUD compared to DPP4i”

    Humansversus DPP4 inhibitor reference, propensity-score matched cohort18 monthsn = 6,565

    Relative efficacy of GLP-1 and GLP-1/GIP receptor agonists in the prevention of alcohol-use disorders using a target trial emulation approach

    Diabetes, obesity & metabolism

More on Liraglutide

Effects

11

Cognitive function

downin humans3

3 studies
  1. Alcohol use disorder is linked with worse cognitive function in humans (lifetime AUD history) (estimate = -0.092, 95% CI [-0.173, -0.010], p = 0.03).

    “lifetime AUD was significantly associated with steeper age-related decline for both the Total Composite score (interaction estimate = -0.092, 95% CI [-0.173, -0.010], p = 0.03)”

    Humanslifetime AUD history

    Lifetime alcohol use disorder linked to faster cognitive aging

    medRxiv : the preprint server for health sciencesPreprint

  2. Alcohol use disorder is linked with worse cognitive function in humans.

    “AUD+ was significantly associated with lower scores of cognition and memory function relative to AUD- individuals.”

    Humans

    Impact of alcohol use disorder on cognition in correlation with aging: a community-based retrospective cohort study

    Alcohol and alcoholism (Oxford, Oxfordshire)

  3. Alcohol use disorder is linked with worse cognitive function in AUD vs CC subjects.

    “Analysis of emotion identification revealed group and age main (p = .02; d = .53 & .003; d = .50, respectively) and interaction effects (p = .05; d = .41).”

    Humansin AUD vs CC subjects

    Age as a potential modulator of alcohol-related deficits

    Alcohol (Fayetteville, N.Y.)

Telomere length

no changein humans2downin humans1

3 studies
  1. Alcohol use disorder was not clearly linked with telomere length in humans (comparing individuals with AUD and healthy controls) (p = 0.073).

    “Telomere length did not differ between individuals with AUD and HC (p = 0.073)”

    Humanscomparing individuals with AUD and healthy controlsmales

    Association between telomere length with alcohol use disorder and internalizing/externalizing comorbidities in a Brazilian male sample

    Alcohol (Fayetteville, N.Y.)

  2. Alcohol use disorder is linked with lower telomere length in alcohol use disorder patients vs controls (p < 0.001).

    “alcohol use disorder patients had significantly shorter telomere lengths (p < 0.001)”

    Humansin alcohol use disorder patients vs controls

    Smoking and diabetes cause telomere shortening among alcohol use disorder patients

    Scientific reports

  3. Alcohol use disorder was not clearly linked with telomere length in humans.

    “No significant association of AUD with TL and mtDNAcn was detected.”

    Humanswhole blood and brain

    Biological aging markers in blood and brain tissue indicate age acceleration in alcohol use disorder

    Alcohol, clinical & experimental research

More on Telomere length

DNAmTL

downin humans2

2 studies
  1. Alcohol use disorder is linked with lower DNAmTL in humans (compared to stimulant use disorder and controls) (β = 0.0150, p-value = 0.087).

    “SUD subgroup analysis showed a nominally lower brain DNAmTL in subjects with alcohol use disorder, compared to stimulant use disorder and controls (β = 0.0150, p-value = 0.087).”

    Humanscompared to stimulant use disorder and controlsprefrontal cortex

    Within subject cross-tissue analyzes of epigenetic clocks in substance use disorder postmortem brain and blood

    American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics

  2. Alcohol use disorder is linked with lower DNAmTL in humans (adjusted for age, sex, race, and blood cell composition) (-0.11 kb/year, p = 4.0 × 10−12).

    “DNAmTL was 0.11-kilobases shorter per year in AUD compared to HC after adjustment for age, sex, race, and blood cell composition (p = 4.0 × 10−12).”

    Humansadjusted for age, sex, race, and blood cell composition

    Alcohol use disorder is associated with DNA methylation-based shortening of telomere length and regulated by TESPA1: implications for aging

    Molecular psychiatry

More on DNAmTL

Facial aging

upin humans1OR 1.02

1 study
  1. Alcohol use disorder is linked with higher facial aging in humans (Genetic liability assessed by two-sample Mendelian randomisation) (OR = 1.02).

    “Alcohol use disorder increased facial ageing (OR = 1.02).”

    HumansGenetic liability assessed by two-sample Mendelian randomisation

    Biological age acceleration associated with mental and behavioural disorders: Evidence from the UK biobank cohort

    Journal of affective disorders

More on Facial aging

Postural stability

downin humans1

1 study
  1. Alcohol use disorder is linked with worse postural stability in 11 conditions, especially standing with feet together or performing mental math.

    “By contrast, the MCI + AUD and AUD groups exhibited significantly greater age effects than controls in 11 conditions”

    Humansin 11 conditions, especially standing with feet together or performing mental math

    Recent drinking in alcohol use disorder as a modifiable risk factor of postural tremor and instability in mild cognitive impairment: An initial study

    Alcohol, clinical & experimental research

CausAge

no changein humans1

1 study
  1. Alcohol use disorder was not clearly linked with CausAge in humans.

    “none of the causality-enriched epigenetic clocks demonstrated significant associations with AUD.”

    Humansn = 615

    Alcohol and aging: Next-generation epigenetic clocks predict biological age acceleration in individuals with alcohol use disorder

    Alcohol, clinical & experimental research

More on CausAge

Pace of epigenetic aging

upin humans1

1 study
  1. Alcohol use disorder is linked with higher pace of epigenetic aging in humans (β = .186, p < .021).

    “PTSD (β = .199) and AUD (β = .186) were associated with a quickened pace of epigenetic aging over time (ps < .021).”

    Humans5.58 yearsn = 171

    PTSD and Alcohol Use Disorders Predict the Pace of Cellular Aging

    Journal of mood and anxiety disorders

More on Pace of epigenetic aging

White matter hyperintensity volume

upin humans1

1 study
  1. Alcohol use disorder is linked with higher white matter hyperintensity volume in HIV-positive individuals.

    “the comorbid group showed faster acceleration than the HIV-only group.”

    Humansin HIV-positive individuals

    Age-Accelerated Increase of White Matter Hyperintensity Volumes Is Exacerbated by Heavy Alcohol Use in People Living With HIV

    Biological psychiatry

More on White matter hyperintensity volume

Brain age

upin silico1

1 study
  1. Alcohol use disorder increases brain age in silico (Mendelian randomization analysis) (β = 0.118, p = 0.044).

    “MR analyses revealed limited evidence for a causal effect of AUD on accelerated brain ageing (β = 0.118, p = 0.044).”

    In silicoMendelian randomization analysis

    Associations between alcohol use and accelerated biological ageing

    Addiction biology

More on Brain age

Activities of daily living

downin humans1

1 study
  1. Alcohol use disorder is linked with worse activities of daily living in PLWH.

    “In PLWH, medical comorbidities and alcohol use disorder (AUD)/substance use disorder (SUD) histories significantly contributed to poor physical and motor ADLs.”

    Humansin PLWHn = 41

    The effects of mood and cognition on daily functioning and quality of life in older people living with HIV and people with Parkinson's disease

    Neuropsychology

All 11

Associations

36

Dementia

upin humans5HR 3.73

5 studies
  1. Alcohol use disorder is linked with a higher risk of dementia in humans (HR=3.73 [95% CI 3.52-3.95]).

    “AUD was associated with all-cause dementia (HR=3.73 [95% CI 3.52-3.95])”

    Humansfemales

    Alcohol use disorder is linked to higher dementia risk in women

    medRxivPreprint

  2. Alcohol use disorder is associated with dementia in humans.

    “Mental and behavioral disorders due to the use of alcohol, intracranial injury, Parkinson's disease, chronic fatigue, intellectual disabilities, pneumonia, and epilepsy were also more often documented 60 months before the diagnosis.”

    Humans60 months before diagnosis

    Documentation of prodromal features and risk factors of dementia disease in primary care practice

    Journal of Alzheimer's disease : JAD

  3. Alcohol use disorder is associated with dementia in humans (Alcohol use disorder alone versus controls in Sweden) (aHR 4.6, 95% CI 4.5–4.6).

    “Dementia rates were increased in AUD alone [adjusted hazard ratio (aHR) = 4.6, 95% confidence interval (CI) = 4.5-4.6]”

    HumansAlcohol use disorder alone versus controls in Swedenmedian follow-up 8.9 yearsn = 128,884

    Disentangling the contributions of alcohol use disorder and alcohol-related liver disease towards dementia: A population-based cohort study

    Addiction (Abingdon, England)

  4. Alcohol use disorder is associated with dementia in humans.

    “Alcohol use disorder is also associated with an increased risk of dementia, particularly early-onset dementia.”

    Review

    Effects of Alcohol on the Central Nervous System

    Brain and nerve = Shinkei kenkyu no shinpo

  5. Alcohol use disorder raises the risk of dementia in humans (tripled the risk).

    “alcohol use disorders tripled the risk of dementia”

    Review

    Neurodegenerative effects of chronic alcohol consumption: a systematic review

    Cuaderno de odontología. Revista científica.

More on Dementia

Vascular dementia

upin humans2

2 studies
  1. Alcohol use disorder is linked with a higher risk of vascular dementia in humans (3.96 [3.44-4.56]).

    “with strongest associations for mixed (5.03 [3.88-6.51]), unspecified (4.29 [3.92-4.70]), and vascular dementia (3.96 [3.44-4.56])”

    Humansfemales

    Alcohol use disorder is linked to higher dementia risk in women

    medRxivPreprint

  2. Alcohol use disorder is associated with vascular dementia in humans (Alcohol use disorder alone versus controls) (aHR 2.3, 95% CI 2.2–2.5).

    “AUD alone was also associated with increased rates of vascular dementia (aHR = 2.3, 95% CI = 2.2-2.5)”

    HumansAlcohol use disorder alone versus controlsmedian follow-up 8.9 yearsn = 128,884

    Disentangling the contributions of alcohol use disorder and alcohol-related liver disease towards dementia: A population-based cohort study

    Addiction (Abingdon, England)

More on Vascular dementia

Tirzepatide

downin humans2HR 0.47–0.61

2 studies
  1. Tirzepatide is linked with a lower risk of alcohol use disorder in humans (compared with sodium-glucose cotransporter-2 inhibitors, in adults with type 2 diabetes) (HR 0.61 (95% CI 0.46-0.83)).

    “Both semaglutide (HR, 0.54; 95% CI, 0.45-0.64) and tirzepatide (HR, 0.61; 95% CI, 0.46-0.83) were associated with significantly lower risks of hospitalization or ED visits for AUD than SGLT2i use.”

    Humanscompared with sodium-glucose cotransporter-2 inhibitors, in adults with type 2 diabetesn = 69,166

    Semaglutide, Tirzepatide, and Risk of Alcohol Use Disorder in Type 2 Diabetes: A Target Trial Emulation

    ADA Scientific Sessions 2026 abstract

  2. Tirzepatide is linked with a lower risk of alcohol use disorder in humans (versus DPP4 inhibitor reference, propensity-score matched cohort) (HR 0.47 [95% CI 0.29, 0.75]).

    “Tirzepatide and semaglutide (but not liraglutide or dulaglutide) were associated with significant risk reduction of incident AUD compared to DPP4i”

    Humansversus DPP4 inhibitor reference, propensity-score matched cohort18 monthsn = 7,165

    Relative efficacy of GLP-1 and GLP-1/GIP receptor agonists in the prevention of alcohol-use disorders using a target trial emulation approach

    Diabetes, obesity & metabolism

More on Tirzepatide

Semaglutide

downin humans2HR 0.54–0.68

2 studies
  1. Semaglutide is linked with a lower risk of alcohol use disorder in humans (compared with sodium-glucose cotransporter-2 inhibitors, in adults with type 2 diabetes) (HR 0.54 (95% CI 0.45-0.64)).

    “Both semaglutide (HR, 0.54; 95% CI, 0.45-0.64) and tirzepatide (HR, 0.61; 95% CI, 0.46-0.83) were associated with significantly lower risks of hospitalization or ED visits for AUD than SGLT2i use.”

    Humanscompared with sodium-glucose cotransporter-2 inhibitors, in adults with type 2 diabetesn = 162,014

    Semaglutide, Tirzepatide, and Risk of Alcohol Use Disorder in Type 2 Diabetes: A Target Trial Emulation

    ADA Scientific Sessions 2026 abstract

  2. Semaglutide is linked with a lower risk of alcohol use disorder in humans (versus DPP4 inhibitor reference, propensity-score matched cohort) (HR 0.68 [95% CI 0.52, 0.89]).

    “Tirzepatide and semaglutide (but not liraglutide or dulaglutide) were associated with significant risk reduction of incident AUD compared to DPP4i”

    Humansversus DPP4 inhibitor reference, propensity-score matched cohort18 monthsn = 20,198

    Relative efficacy of GLP-1 and GLP-1/GIP receptor agonists in the prevention of alcohol-use disorders using a target trial emulation approach

    Diabetes, obesity & metabolism

More on Semaglutide

Mortality

no changein humans1upin humans1HR 0.91

2 studies
  1. Alcohol use disorder is associated with mortality in humans (Adjusted HR 0.91 (95% CI 0.54–1.54)).

    “However, in adjusted analysis type of SUD showed no statistically significant association with increased mortality [aHR 0.91 (0.54–1.54)]”

    HumansAlcohol use disorder alone versus opioid use disorder receiving opioid agonist treatment; adjusted analysis1998–2016

    Comparison of mortality and causes of death between treatment-engaged individuals with severe alcohol or opioid use disorder: a prospective 19-year clinical cohort study

    BMC psychiatry

  2. Alcohol use disorder is associated with mortality in humans.

    “These conditions contribute to the increased mortality associated with AUD and are burdensome to patients and caregivers.”

    Review

    Extrahepatic Health Effects of Alcohol Use and Alcohol-associated Liver Disease

    Clinical therapeutics

Alzheimer's disease

upin humans2HR 1.78

2 studies
  1. Alcohol use disorder is associated with Alzheimer's disease in humans (Alcohol use disorder alone versus controls) (aHR 1.4, 95% CI 1.3–1.4).

    “AUD alone was also associated with increased rates of vascular dementia (aHR = 2.3, 95% CI = 2.2-2.5) and Alzheimer's disease”

    HumansAlcohol use disorder alone versus controlsmedian follow-up 8.9 yearsn = 128,884

    Disentangling the contributions of alcohol use disorder and alcohol-related liver disease towards dementia: A population-based cohort study

    Addiction (Abingdon, England)

  2. Alcohol use disorder is linked with a higher risk of Alzheimer's disease in humans (female HR 1.78 (95% CI 1.68-1.90), male HR 1.80 (95% CI 1.71-1.91)).

    “AUD was associated with a higher risk of Alzheimer's disease (female adjusted hazard ratio [HR] = 1.78, 95% confidence interval [CI]: 1.68-1.90, p < 0.001; male adjusted HR = 1.80, 95% CI: 1.71-1.91, p < 0.001)”

    Humans

    Alcohol use disorder is associated with higher risks of Alzheimer's and Parkinson's diseases: A study of US insurance claims data

    Alzheimer's & dementia (Amsterdam, Netherlands)

More on Alzheimer's disease

Fragility fracture

upin humans2OR 1.49

2 studies
  1. Alcohol use disorder is linked with a higher risk of fragility fracture in older persons living with HIV (8%; 95% CI 7%-8%).

    “diagnosis of alcohol use disorder (serious falls [4%; 95% CI 4%-5%]; fractures [8%; 95% CI 7%-8%])”

    Humansin older persons living with HIV

    Assessing the contributions of modifiable risk factors to serious falls and fragility fractures among older persons living with HIV

    Journal of the American Geriatrics Society

  2. Alcohol use disorder is linked with a higher risk of fragility fracture in humans (HIV on ART) (OR 1.49; 95% CI: 1.31 to 1.70).

    “Other risk factors included the diagnosis of alcohol use disorder (OR 1.49; 95% CI: 1.31 to 1.70)”

    HumansHIV on ART

    Brief Report: Are Serious Falls Associated With Subsequent Fragility Fractures Among Veterans Living With HIV?

    Journal of acquired immune deficiency syndromes (1999)

More on Fragility fracture

Telomere length

downin humans2

2 studies
  1. Alcohol use disorder is associated with telomere length in humans (β = -0.06, 95% CI -0.10 to -0.02).

    “Higher genetically-predicted AUD (inverse variance-weighted (IVW) β = -0.06, 95% confidence interval (CI): -0.10 to -0.02, p = 0.001) was associated with shorter telomere length.”

    HumansGenetically predicted alcohol use disorder; inverse variance-weighted Mendelian randomization

    Alcohol consumption and telomere length: Mendelian randomization clarifies alcohol's effects

    Molecular psychiatry

  2. Alcohol use disorder is associated with telomere length in humans (99 patients and 99 controls paired by age and smoking status).

    “Our results showed that the mean TL was shorter in patients with AUD than in controls.”

    Humans99 patients and 99 controls paired by age and smoking statusmales

    Genetic susceptibility to telomere shortening through the rs2293607 polymorphism is associated with a greater risk of alcohol use disorder

    Mechanisms of ageing and development

More on Telomere length

Age-associated decline in inferred neuron-to-neuron communication

upin humans1

1 study
  1. Alcohol use disorder is associated with age-associated decline in inferred neuron-to-neuron communication in humans.

    “Inferred neuron-to-neuron communication declined with age, with greater declines in AUD.”

    Humanscaudate nucleus

    Aging in a human brain region shares gene patterns with disorders

    bioRxivPreprint

Brain volume

downin humans1

1 study
  1. Alcohol use disorder is associated with brain volume in humans.

    “Neuroimaging studies have shown that alcohol use disorder is associated with reduced brain volume”

    Reviewbrain

    Effects of Alcohol on the Central Nervous System

    Brain and nerve = Shinkei kenkyu no shinpo

All 36

Trial sponsors

Funding

10 grants since 2018

National Institute on Alcohol Abuse and Alcoholism$3MNational Institute for Health Research£2.8MAlzheimer's Association

Contains public sector information licensed under the Open Government Licence v3.0.

How this record changed

  1. Summary rewritten as its findings changed.

    As it read before

    A human preprint links alcohol use disorder to higher dementia and vascular dementia risk in women. Another human preprint associates lifetime alcohol use disorder history with impaired cognitive function.

  2. Summary written from the findings.

Latest

Dec 2025: 11Jan 2026: 10Feb 2026: 11Mar 2026: 10Apr 2026: 6May 2026: 3Jun 2026: 8Jul 2026: 4Aug 2026: 7Sep 2026: 7Oct 2026: 9Nov 2026: 1399 papers in 12 months
AHA Scientific Sessions 2026 Abstract

Sleep patterns linked to irregular heartbeat risk in Fitbit users

Each extra hour of deep sleep was linked to 13.5% lower relative risk; each extra hour of rapid eye movement sleep to 11.3% lower risk.Each extra hour of deep sleep was linked to 13.5% lower relative risk; each extra hour of rapid eye movement sleep to 11.3% lower risk.

Cohort · 43,704 peopleBiomarkers
bioRxiv

Aging in a human brain region shares gene patterns with disorders

An observational analysis of caudate tissue from 178 human donors found age-related gene activity changes that appeared earlier in donors with alcohol use disorder.An observational analysis of caudate tissue from 178 human donors found age-related gene activity changes that appeared earlier in donors with alcohol use disorder.

Preprint: cross-sectional · 178 peopleAI & data

See all 283 papers on alcohol use disorder